Abstract:Purpose To unravel the oncogenic role of CDCA4 in different cancers from the perspective of tumor immunity. Methods Raw data on CDCA4 expression in tumor samples and paracancerous samples were obtained from TCGA and GTEX databases. In addition, we investigated pathological stages and the survival analysis of CDCA4 in pan-cancer across Gene Expression Profiling Interactive Analysis (GEPIA) database. Cox Proportional Hazards Model shows that high CDCA4 levels are associated with several vital indicators in oncology. On the one hand, we explored the correlation between CADA4 expression and tumor immune infiltration by the TIMER tool; On the other hand, we utilized the methods of CIBERSORT and ESTIMATE computational to evaluate the proportion of tumor infiltrating immune cells (TIIC) and the amounts of stromal and immune components based on TCGA database. The use of antineoplastic drugs and the expression of CDCA4 also showed a high correlation via linear regression. Protein–Protein Interaction analysis was performed in the GeneMANIA database, and enrichment analysis was performed and predicted signaling pathways were identified by using Gene Ontology and Kyoto Encyclopedia of Genes. The correlation between CDCA4 expression with Copy number variations (CNV) and methylation is detailed, respectively. Molecular biology experiments including Western blotting, flow cytometry, EDU staining, Transwell and Wound Healing assay to validate the cancer promoting role of CDCA4 in hepatocellular carcinoma (HCC). Results Most tumors highly expressed CDCA4. Elevated CDCA4 expression was associated with poor OS and DFS. There was a significant correlation between CDCA4 expression and TITCs. Moreover, markers of TIICs exhibited distinct patterns of CDCA4 associated immune infiltration. In addition, we pay attention to the association between the expression of CDCA4 and the use of the anti-tumor drugs. CDCA4 is related to biological progress (BP), cellular component (CC) and molecular function (MF). Dopaminergic Synapse, AMPK, Sphingolipid, Chagas Disease, mRNA Surveillance were significantly enriched pathways in positive and negative correlation genes with CDCA4. CNV is thought to be a positive correlation with CDCA4 expression. Conversely, methylation is negative correlation with CDCA4 expression. Molecular biology experiments confirm a cancer promoting role for CDCA4 in HCC Conclusion CDCA4 may serve as a biomarker for cancer immunologic infiltration and poor prognosis, providing a new way of thinking for cancer treatment.

Expression of HDAC4 in human lung adenocarcinoma and its relationship with chemotherapy resistance

Hdac 1/4-Mediated Silencing of Microrna-200b Promotes Chemoresistance in Human Lung Adenocarcinoma Cells

Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study

Identification of ING4 (inhibitor of Growth 4) As a Modulator of Docetaxel Sensitivity in Human Lung Adenocarcinoma

Identification of ING 4 ( Inhibitor of Growth 4 ) as a Modulator of Docetaxel Sensitivity in Human Lung Adenocarcinoma

Prognostic Values of HE4 Expression in Patients with Cancer: a Meta-Analysis

HE4 overexpression decreases pancreatic cancer Capan-1 cell sensitivity to paclitaxel via cell cycle regulation

Research on the Mechanisms of Docetaxel-Resistant Human Lung Adenocarcinoma

Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling

HEATR1 Deficiency Promotes Chemoresistance Via Upregulating ZNF185 and Downregulating SMAD4 in Pancreatic Cancer

HDAC-an important target for improving tumor radiotherapy resistance

ADH4-a potential prognostic marker for hepatocellular carcinoma with possible immune-related implications

Hyper-acetylation contributes to the sensitivity of chemo-resistant prostate cancer cells to histone deacetylase inhibitor Trichostatin A

Chd4 is Associated with Poor Prognosis of Non- Small Cell Lung Cancer Patients Through Promoting Tumor Cell Proliferation

HDACs Alters Negatively to the Tumor Immune Microenvironment in Gynecologic Cancers.

A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors

HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma

Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy.

The Expression of Histone Deacetylase HDAC1 Correlates with the Progression and Prognosis of Gastrointestinal Malignancy

A novel disulfidptosis-related prognostic gene signature and experimental validation identify ACTN4 as a novel therapeutic target in lung adenocarcinoma

Histone Deacetylase HDAC1 Expression Correlates with the Progression and Prognosis of Lung Cancer: A Meta-Analysis.